AR059462A1 - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos - Google Patents

Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Info

Publication number
AR059462A1
AR059462A1 ARP060101766A ARP060101766A AR059462A1 AR 059462 A1 AR059462 A1 AR 059462A1 AR P060101766 A ARP060101766 A AR P060101766A AR P060101766 A ARP060101766 A AR P060101766A AR 059462 A1 AR059462 A1 AR 059462A1
Authority
AR
Argentina
Prior art keywords
peptides derived
methods
pharmaceutical compositions
clear
caseina
Prior art date
Application number
ARP060101766A
Other languages
English (en)
Spanish (es)
Inventor
Jose Mario Iscovich
Nissim Silankovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of AR059462A1 publication Critical patent/AR059462A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ARP060101766A 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos AR059462A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US68869705P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
AR059462A1 true AR059462A1 (es) 2008-04-09

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101766A AR059462A1 (es) 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Country Status (18)

Country Link
US (2) US7968513B2 (enExample)
EP (1) EP1890720B1 (enExample)
JP (1) JP5247429B2 (enExample)
KR (2) KR20130122979A (enExample)
CN (1) CN106421749A (enExample)
AR (1) AR059462A1 (enExample)
AU (1) AU2006242842B2 (enExample)
BR (1) BRPI0611301A2 (enExample)
CA (1) CA2607155C (enExample)
CL (1) CL2011000039A1 (enExample)
EA (1) EA016039B1 (enExample)
ES (1) ES2400511T3 (enExample)
IN (1) IN2014DN10391A (enExample)
MX (1) MX2007013866A (enExample)
NZ (1) NZ563936A (enExample)
PL (1) PL1890720T3 (enExample)
UY (1) UY29515A1 (enExample)
WO (1) WO2006117784A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos
JP5507555B2 (ja) * 2008-06-30 2014-05-28 チョ−エー・ファーム・カンパニー・リミテッド 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
CA2797658C (en) * 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
ES2759980T3 (es) * 2012-03-19 2020-05-12 Mileutis Ltd Péptidos para el manejo de la lactación
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
NZ753824A (en) * 2016-11-09 2022-08-26 Charles Sturt Univ Livestock supplement and use thereof
AU2017376402B2 (en) * 2016-12-13 2021-10-28 Dsm Ip Assets B.V. PUFA salt formulations (I)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
US20230106635A1 (en) * 2020-02-19 2023-04-06 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
EP4329790A1 (en) * 2021-04-28 2024-03-06 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions
CN120379680A (zh) * 2022-11-17 2025-07-25 米勒尤迪斯公司 用于调节乳腺病症和病状的组合物和方法
CN121358342A (zh) * 2023-05-16 2026-01-16 米勒尤迪斯公司 提升的乳质
WO2026159713A1 (en) * 2025-01-23 2026-07-30 Mileutis Ltd. A method of increasing milk production

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
ES2149771T3 (es) * 1991-04-19 2000-11-16 Univ Melbourne Produccion de fosfopeptidos a partir de la caseina.
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU775999B2 (en) 1999-08-24 2004-08-19 Meiji Seika Pharma Co., Ltd. Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
JPWO2002072629A1 (ja) * 2001-03-09 2004-07-02 明治製菓株式会社 免疫増強剤
KR20070007128A (ko) 2004-03-01 2007-01-12 펩테라 파마슈티컬스 엘티디. 카제인 파생 펩타이드들과 그의 치료적 사용들
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos

Also Published As

Publication number Publication date
JP5247429B2 (ja) 2013-07-24
EA200702401A1 (ru) 2008-08-29
WO2006117784A2 (en) 2006-11-09
IN2014DN10391A (enExample) 2015-08-14
BRPI0611301A2 (pt) 2010-08-31
US7968513B2 (en) 2011-06-28
EA016039B1 (ru) 2012-01-30
JP2008540399A (ja) 2008-11-20
CA2607155C (en) 2016-09-13
NZ563936A (en) 2010-03-26
CL2011000039A1 (es) 2011-06-10
CA2607155A1 (en) 2006-11-09
EP1890720A2 (en) 2008-02-27
WO2006117784A3 (en) 2009-05-22
US20090069218A1 (en) 2009-03-12
US8338363B2 (en) 2012-12-25
ES2400511T3 (es) 2013-04-10
US20110212886A1 (en) 2011-09-01
KR20080012933A (ko) 2008-02-12
EP1890720B1 (en) 2013-01-09
KR101340676B1 (ko) 2013-12-18
CN106421749A (zh) 2017-02-22
AU2006242842A1 (en) 2006-11-09
PL1890720T3 (pl) 2013-06-28
EP1890720A4 (en) 2010-05-26
AU2006242842B2 (en) 2011-12-08
KR20130122979A (ko) 2013-11-11
UY29515A1 (es) 2007-11-30
MX2007013866A (es) 2008-04-07

Similar Documents

Publication Publication Date Title
US10264766B2 (en) Antimicrobial compounds and compositions, and uses thereof
US10793587B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
DOP2019000250A (es) Composicion farmaceutica que comprende selexipag
US11311511B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
PE20130589A1 (es) Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
CL2011000039A1 (es) Uso de un fosfopeptido que comprende la segunda serp-serp-serp-glu-glu que sirve para preparar una composicion farmaceutica util para aumentar el rendimiento lechero de ganado en lactancia luego de la paricion comparado con el rendimiento lechero antes de la paricion (divisional de la sol. 1028-2006).
BR112015006828A2 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar uma doença em um paciente em necessidade do tratamento; e método para modular a atividade de uma proteína ire1
MY199821A (en) Modified lipidated relaxin b chain peptides and their therapeutic use
MX2018014631A (es) Formulacion de neurotoxina.
RU2002115406A (ru) Соединение, обладающее свойствами высвобождения гормона роста
WO2016060921A1 (en) Formulations for histatin protectives and therapeutics
US20200296998A1 (en) Feed compositions enhancing zootechnical performance in livestock
RU2016121401A (ru) Устойчивые при хранении лиофилизованные составы трипептидов
PH12020500342A1 (en) New disinfectant for hatcheries
ES2888999T3 (es) Uso de una composición bacteriana para tratar infecciones del pie en los ungulados
BR112017019431A2 (pt) material de implante de compósito
BR112019003890A2 (pt) uso de oligossacarídeos de leite humano em engordamento de bezerros
CN102389030A (zh) 枯草杆菌糖肽素168的用途
FR2947454B1 (fr) Innovation destinee a l'homme et l'animal a base d'inhibiteurs naturels des proteases humaines associes a des plantes medicinales, indiquees dans toutes les pathologies
RU2009100745A (ru) Способ лечения слюннокаменной болезни
Murray Touch: Reflections on Human‐Animal Health and Hierarchy
ES2246691B1 (es) Composicion de acido l(+)-lactico de origen natural y organico.
McCosker et al. A single-shot 5-in-1 vaccination at the time of dehorning/castration and prevalence of ‘missing’animals at future mustering events

Legal Events

Date Code Title Description
FC Refusal